Antidepressant effect detected on proton magnetic resonance spectroscopy in drug-naïve female patients with first-episode major depression

Psychiatry and Clinical Neurosciences

Volumn 63, Issue 3, 2009, Pages 350-356

  Kaymak, Semra Ulusoy ^a   Demir, Başaran ^b   Òuz, Kader Karli ^b   Şentürk, Senem ^b   Ulù, Berna ^b  

^a ANKARA ONCOLOGY EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Dorsolateral prefrontal cortex; Major depressive disorder; Myoinositol; N acetyl aspartate; Proton magnetic resonance spectroscopy

Indexed keywords

CHOLINE; CREATINE; ESCITALOPRAM; FLUOXETINE; INOSITOL; N ACETYLASPARTIC ACID; PAROXETINE; SERTRALINE;

ADULT; ARTICLE; BRAIN METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG WITHDRAWAL; FEMALE; HUMAN; MAJOR DEPRESSION; MENTAL PATIENT; METABOLITE; PATIENT COMPLIANCE; PREFRONTAL CORTEX; PROTON NUCLEAR MAGNETIC RESONANCE; TREATMENT DURATION;

ADULT; ANTIDEPRESSIVE AGENTS; ASPARTIC ACID; CASE-CONTROL STUDIES; CHOLINE; CREATINE; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; INOSITOL; MAGNETIC RESONANCE SPECTROSCOPY; MIDDLE AGED; PREFRONTAL CORTEX; PROTONS;

EID: 65649090233     PISSN: 13231316     EISSN: 14401819     Source Type: Journal    
DOI: 10.1111/j.1440-1819.2009.01951.x     Document Type: Article

References (40)

1. Ustun TB, Ayuso-Mateos JL, Chatterji S, Mathers C, Murray CJ. Global burden of depressive disorders in the year 2000. Br. J. Psychiatry 2004 184 : 386 392. (Pubitemid 38624764)
2. Davidson RJ, Pizzagalli D, Nitschke JB, Putnam K. Depression: Perspectives from affective neuroscience. Annu. Rev. Psychol. 2002 53 : 545 574.
3. Fossati P, Ergis AM, Allilaire JF. Executive functioning in unipolar depression: A review. Encephale 2002 28 : 97 107. (Pubitemid 34627312)
4. Hastings RS, Parsey RV, Oquendo MA, Arango V, Mann JJ. Volumetric analysis of the prefrontal cortex, amygdala, and hippocampus in major depression. Neuropsychopharmacology 2004 29 : 952 959. (Pubitemid 38526795)
5. Fitzgerald PB, Oxley TJ, Leird AR, Kulkarni J, Egan GF, Daskalakis ZJ. An analysis of functional neuroimaging studies of dorsolateral prefrontal cortical activity in depression. Psychiatry Res. 2006 148 : 33 45. (Pubitemid 44679820)
6. Narita H, Odawara T, Iseki E, Kosaka K, Hirayasu Y. Psychomotor retardation correlates with frontal hypoperfusion and the Modified Stroop Test in patients with major depression under 60 years old. Psychiatry Clin. Neurosci. 2004 58 : 389 395. (Pubitemid 39108541)
7. 1H magnetic resonance spectroscopy findings in major depressive disorder: A meta-analysis. Psychiatry Res. 2006 147 : 1 25. (Pubitemid 44067434)
8. Bielau H, Steiner J, Mawrin C et al. Dysregulation of GABAergic neurotransmission in mood disorders: A postmortem study. Ann. N. Y. Acad. Sci. 2007 1096 : 157 169. (Pubitemid 47092509)
9. Rajkowska G, Miguel-Hidalgo JJ, Wei J et al. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol. Psychiatry 1999 45 : 1085 1098. (Pubitemid 29236550)
10. Stanley JA. In vivo magnetic resonance spectroscopy and its application to neuropsychiatric disorders. Can. J. Psychiatry 2002 47 : 315 326. (Pubitemid 34728752)
11. Kumar A, Thomas A, Lavretsky H et al. Frontal white matter biochemical abnormalities in late-life major depression detected with proton magnetic resonance spectroscopy. Am. J. Psychiatry 2002 159 : 630 636. (Pubitemid 34274946)
12. 1H Magnetic resonance spectroscopy study of dorsolateral prefrontal cortex in unipolar mood disorder patients. Psychiatry Res. 2005 138 : 131 139. (Pubitemid 40568785)
13. Farchine TR, Moore GJ, Rosenberg DR. Proton magnetic resonance spectroscopic imaging in pediatric major depression. Biol. Psychiatry 2002 52 : 86 92. (Pubitemid 34756553)
14. Caetano SC, Fonseca M, Olvera RL et al. Proton spectroscopy study of the left dorsolateral prefrontal cortex in pediatric depressed patients. Neurosci. Lett. 2005 384 : 321 326. (Pubitemid 40836022)
15. Frey R, Metzler D, Fischer P, Heiden A. Myo-inositol in depressive and healthy subjects determined by frontal 1H-magnetic resonance spectroscopy at 15 Tesla. J. Psychiatr. Res. 1998 32 : 411 420. (Pubitemid 28491247)
16. Gruber S, Frey R, Mlynarik V et al. Quantification of metabolic differences in the frontal brain of depressive patients and controls obtained by 1H-MRS at 3 Tesla. Invest. Radiol. 2003 38 : 403 408. (Pubitemid 36791333)
17. Migual-Hidalgo JJ, Rajkowska G. Comparison of prefrontal cell pathology between depression and alcohol dependence. J. Psychiatr. Res. 2003 37 : 411 420. (Pubitemid 36808814)
18. Pav M, Kovaru H, Fiserova A, Havrdova E, Lisa V. Neurobiological aspects of depressive disorder and antidepressant treatment: Role of glia. Physiol. Res. 2008 57 : 151 164.
19. First RLS, Gibbon M, Williams JBW. Structured Clinical Interview of DSM IV Axis I Disorders SCID-I. Biometrics Research Department, New York State Psychiatric Institute, New York, 1997.
20. Hamilton M. Development of a rating scale; for primary depressive illness. Br. J. Soc. Clin. Psychol. 1967 6 : 278 296.
21. Akdemir A, Turkcapar MH, Orsel SD, Demirergi N, Dag I, Ozbay MH. Reliability and validity of the Turkish version of the Hamilton depression rating scale. Compr. Psychiatry 2001 42 : 161 165. (Pubitemid 32207252)
22. O'Leary D, Costello F, Gormley N, Webb M. Remission onset and relapse in depression, an 18-month prospective study of course for 100 first admission patients. J. Affect. Disord. 2000 57 : 159 171. (Pubitemid 30119968)
23. Sadock B, Sadock V. Kaplan and Sadock's Comprehensive Textbook of Psychiatry, 7th edn, vol. 1 S. 769. Lippincott, Williams and Wilkins, Philadelphia, PA, 2000.
24. Chapman JP, Chapman LJ. Handedness of hypothetically psychosis-prone subjects. J. Abnorm. Psychol. 1987 96 : 89 93. (Pubitemid 17085613)
25. Nalcaci E, Kalaycioglu C, Gunes E, Cicek M. Reliability and validity of a handedness questionnaire. Turk Psikiyatr. Derg. 2002 13 : 99 106.
26. Murata T, Kimura H, Omori M et al. MRI white matter hyperintensities, 1H-MR spectroscopy and cognitive function in geriatric depression: A comparison of early- and late-onset cases. Int. J. Geriatr. Psychiatry 2001 16 : 1129 1135. (Pubitemid 34044179)
27. Davis S, Thomas A, Perry R, Oakley A, Kalaria RN, O'Brien JT. Glial fibrillary acidic protein in late life major depressive disorder: An immunocytochemical study. J. Neurol. Neurosurg. Psychiatry 2002 73 : 556 560. (Pubitemid 35246811)
28. Fukuzako H, Hashiguchi T, Sakamoto Y et al. Metabolite changes with age measured by proton magnetic resonance spectroscopy in normal subjects. Psychiatry Clin. Neurosci. 1997 51 : 261 263. (Pubitemid 27362562)
29. Miguel-Hidalgo JJ, Baucom C, Dilley G et al. Glial fibrillary acidic protein immunoreactivity in the prefrontal cortex distinguishes younger from older adults in major depressive disorder. Biol. Psychiatry 2000 48 : 861 873.
30. Si X, Miguel-Hidalgo JJ, O'Dwyer G, Stockmeier CA, Rajkowska G. Age-dependent reductions in the level of glial fibrillary acidic protein in the prefrontal cortex in major depression. Neuropsychopharmacology 2004 29 : 2088 2096. (Pubitemid 39486561)
31. Moore GJ, Galloway MP. Magnetic resonance spectroscopy: Neurochemistry and treatment effects in affective disorders. Psychopharmacol. Bull. 2002 36 : 5 23.
32. Pfleiderer B, Michael N, Erfurth A et al. Effective electroconvulsive therapy reverses glutamate/glutamine deficit in the left anterior cingulum of unipolar depressed patients. Psychiatry Res. 2003 122 : 185 192. (Pubitemid 36412193)
33. Michael N, Ertfuth A, Ohrmann P, Arolt V, Heindel W, Pfleiderer B. Metabolic changes within the left dorsolateral prefrontal cortex occurring with electroconvulsive therapy in patients with treatment resistant unipolar depression. Psychol. Med. 2003 33 : 1277 1284. (Pubitemid 37265215)
34. Ongur D, Drevets WC, Price JL. Glial reductions in the subgenual prefrontal cortex in mood disorders. Proc. Natl Acad. Sci. USA 1998 95 : 13 290 13 295. (Pubitemid 28509564)
35. Binesh N, Kumar A, Hwang S, Mintz J, Thomas MA. Neurochemistry of late-life depression: A pilot two dimensional MR spectroscopic study. J. Magn. Reson. Imaging 2004 20 : 1039 1045. (Pubitemid 39577907)
36. Shimon H, Agam G, Belmaker RH, Hyde TM, Kleinman JE. Reduced frontal cortex inositol levels in post-mortem brain of suicide victims and patients with bipolar disorder. Am. J. Psychiatry 1997 154 : 1148 1150. (Pubitemid 27328834)
37. Rajkowska G. Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells. Biol. Psychiatry 2000 48 : 766 777.
38. Inazu M, Takeda H, Ikoshi H, Sugisawa M, Uchida Y, Matsumiya T. Pharmacological characterization and visualization of the glial serotonin transporter. Neurochem. Int. 2001 39 : 39 49. (Pubitemid 32304454)
39. Michael N, Gosling M, Reutemann M et al. Metabolic changes after repetitive transcranial magnetic stimulation rTMS of the left prefrontal cortex: A sham-controlled proton magnetic resonance spectroscopy 1H MRS study of healthy brain. Eur. J. Neurosci. 2003 17 : 2462 2468. (Pubitemid 36793755)
40. Malhi SG, Valenzuela M, Wen W, Sachdev P. Magnetic resonance spectroscopy and its applications in psychiatry. Aust. N. Z. J. Psychiatry 2002 36 : 31 43. (Pubitemid 34284996)